{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:32:15Z","timestamp":1767184335543,"version":"build-2238731810"},"reference-count":39,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,3,1]]},"DOI":"10.1542\/pir.21.3.95","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:49:31Z","timestamp":1639183771000},"page":"95-104","source":"Crossref","is-referenced-by-count":20,"title":["Idiopathic Thrombocytopenic Purpura"],"prefix":"10.1542","volume":"21","author":[{"given":"Yu-Waye","family":"Chu","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology,Department of Pediatrics."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Korb","sequence":"additional","affiliation":[{"name":"Division of General Pediatrics, Department of Pediatrics, UCLA School of Medicine,Los Angeles, CA. This work was supported by a Resident Research Grant from the American Academy of Pediatrics (Y-WC). KMS is a Scholar of the Leukemia Society of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology,Department of Pediatrics."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2000,3,1]]},"reference":[{"key":"2021121019243283800_R1","doi-asserted-by":"crossref","unstructured":"Aronis S, Platolouki H, Mitsika A, Haidas S,Constantopoulos A. Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better? Pediatr Hematol Oncol.\u2008\u20081994;11:487-498","DOI":"10.3109\/08880019409141687"},{"key":"2021121019243283800_R2","unstructured":"Beardsley DS, Nathan DG. Platelet abnormalities in infancy and childhood. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood.\u20081998:1585-1630 WB Saunders Philadelphia, Penn"},{"key":"2021121019243283800_R3","doi-asserted-by":"crossref","unstructured":"Blanchette V, Imbach P, Andrew M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet.\u2008\u20081994;344:703-707","DOI":"10.1016\/S0140-6736(94)92205-5"},{"key":"2021121019243283800_R4","doi-asserted-by":"crossref","unstructured":"Blanchette VS, Luke B, Andrew M, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr.\u2008\u20081993;123:990-995","DOI":"10.1016\/S0022-3476(05)80400-7"},{"key":"2021121019243283800_R5","doi-asserted-by":"crossref","unstructured":"Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood immune thrombocytopenic purpura against published guidelines. Lancet.\u2008\u20081997;350:620-623","DOI":"10.1016\/S0140-6736(97)04143-3"},{"key":"2021121019243283800_R6","doi-asserted-by":"crossref","unstructured":"Borgna-Pignatti C, Battisti L, Zecca M,Locatelli F. Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins. Br J Haematol.\u2008\u20081994;88:618-620","DOI":"10.1111\/j.1365-2141.1994.tb05083.x"},{"key":"2021121019243283800_R7","unstructured":"Buchanan GR. ITP. How much treatment is enough? Contemporary Pediatrics\u2008\u20081995;12:23-48"},{"key":"2021121019243283800_R8","doi-asserted-by":"crossref","unstructured":"Buchanan GR, Holtkamp CA. Prenisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. Am J Pediatr Hematol Oncol.\u2008\u20081984;6:355-361","DOI":"10.1097\/00043426-198424000-00001"},{"key":"2021121019243283800_R9","doi-asserted-by":"crossref","unstructured":"Bussel JB. Immune thrombocytopenia in pregnancy: autoimmune and alloimmune. J Repro Immunol.\u2008\u20081997;37:35-61","DOI":"10.1016\/S0165-0378(97)00072-7"},{"key":"2021121019243283800_R10","unstructured":"Bussel JB, Corrigan JJ. Platelet and vascular disorders. In: Miller DR, Baehener RL,eds. Blood Disease of Infancy and Childhood. 7th 1995:878-886 Mosby St. Louis, Mo"},{"key":"2021121019243283800_R11","doi-asserted-by":"crossref","unstructured":"Calpin C, Dick P, Poon A, Feldman W. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adolesc Med.\u2008\u20081998;152:345-347","DOI":"10.1001\/archpedi.152.4.345"},{"key":"2021121019243283800_R12","doi-asserted-by":"crossref","unstructured":"Calverley DC, Jones GW, Kelton JG. Splenic radiation for corticosteroid-resistant immune thrombocytopenia. Ann Intern Med.\u2008\u20081992;116 (12 pt1):977-981","DOI":"10.7326\/0003-4819-116-12-977"},{"key":"2021121019243283800_R13","doi-asserted-by":"crossref","unstructured":"Carcao MD, Zipursky A, Butchart S, Leaker M, Blanchette VS. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura(ITP). Acta Paediatr.\u2008\u20081998;424(suppl):71-74","DOI":"10.1111\/j.1651-2227.1998.tb01239.x"},{"key":"2021121019243283800_R14","doi-asserted-by":"crossref","unstructured":"Davis PW, Williams DA, Shamberger RC. Immune thrombocytopenia: surgical therapy and predictors of response. J Pediatr Surg.\u2008\u20081991;26:407-413","DOI":"10.1016\/0022-3468(91)90987-5"},{"key":"2021121019243283800_R15","unstructured":"Dubansky SA, Boyett JM, Falletta J, et al. Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a pediatric oncology group study. Pediatrics.\u2008\u20081989;84:1068-1071"},{"key":"2021121019243283800_R16","unstructured":"Ein SH. Splenic lesions. In: Ashcraft KW,Holder TM, eds. Pediatric Surgery.\u20081993:535-545 WB Saunders Philadelphia, Penn"},{"key":"2021121019243283800_R17","doi-asserted-by":"crossref","unstructured":"Emmons RV, Reid DM, Cohen RL, et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood.\u2008\u20081996;87:4068-4071","DOI":"10.1182\/blood.V87.10.4068.bloodjournal87104068"},{"key":"2021121019243283800_R18","doi-asserted-by":"crossref","unstructured":"Fujimura K, Takafuta T, Kuriya S, et al. Recombinant human interferon alpha-2b(rh IFN alpha-2b) therapy for steroid resistant idiopathic thrombocytopenic purpura. Am J Hematol.\u2008\u20081996;51:37-44","DOI":"10.1002\/(SICI)1096-8652(199601)51:1<37::AID-AJH7>3.0.CO;2-8"},{"key":"2021121019243283800_R19","unstructured":"Graziano SL. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: Williams WJ, ed. Hematology.\u20081996 McGraw Hill New York, NY"},{"key":"2021121019243283800_R20","doi-asserted-by":"crossref","unstructured":"Halperin DS, Doyle JJ. Is bone marrow examination justified in idiopathic thrombocytopenic purpura? Am J Dis Child.\u2008\u20081988;142:508-511","DOI":"10.1001\/archpedi.1988.02150050046027"},{"key":"2021121019243283800_R21","doi-asserted-by":"crossref","unstructured":"Kattamis AC, Shankar S, Cohen AR. Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G. J Pediatr.\u2008\u20081997;130:281-283","DOI":"10.1016\/S0022-3476(97)70355-X"},{"key":"2021121019243283800_R22","doi-asserted-by":"crossref","unstructured":"Kuhne T, Elinder G, Blanchette VS, Garvey B. Current management issues of childhood and adult immune thrombocytopenic purpura (ITP). Acta Paediatr.\u2008\u20081998;424(suppl):75-81","DOI":"10.1111\/j.1651-2227.1998.tb01240.x"},{"key":"2021121019243283800_R23","doi-asserted-by":"crossref","unstructured":"Kuhne T, Freedman J, Semple JW, Doyle J,Butchart S, Blanchette VS. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr.\u2008\u20081997;130:17-24","DOI":"10.1016\/S0022-3476(97)70305-6"},{"key":"2021121019243283800_R24","doi-asserted-by":"crossref","unstructured":"Kurtzberg J, Stockman JA. Idiopathic autoimmune thrombocytopenic purpura. Adv Pediat.\u2008\u20081994;41:111-134","DOI":"10.1016\/S0065-3101(24)00092-6"},{"key":"2021121019243283800_R25","doi-asserted-by":"crossref","unstructured":"Law C, Maraccio M, Tam P, Heddle N,Kelton JG. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med.\u2008\u20081997;336:1494-1498","DOI":"10.1056\/NEJM199705223362104"},{"key":"2021121019243283800_R26","doi-asserted-by":"crossref","unstructured":"Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch Dis Child.\u2008\u20081994;71:251-253","DOI":"10.1136\/adc.71.3.251"},{"key":"2021121019243283800_R27","doi-asserted-by":"crossref","unstructured":"Medeiros D, Buchanan GR. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood. Pediat Clin North Am.\u2008\u20081996;43:757-171","DOI":"10.1016\/S0031-3955(05)70431-4"},{"key":"2021121019243283800_R28","doi-asserted-by":"crossref","unstructured":"Parker RI, Siegel RS, Ratajczak MZ, Gewirtz AM. Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia. J Pediatr Hematol Oncol.\u2008\u20081998;20:196-201","DOI":"10.1097\/00043426-199805000-00003"},{"key":"2021121019243283800_R29","doi-asserted-by":"crossref","unstructured":"Reid MM. Bone marrow examination before steroids in thrombocytopenic purpura or arthritis. Acta Paediat.\u2008\u20081992;81:1052-1053","DOI":"10.1111\/j.1651-2227.1992.tb12175.x"},{"key":"2021121019243283800_R30","doi-asserted-by":"crossref","unstructured":"Reid MM. Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child.\u2008\u20081995;72:125-128","DOI":"10.1136\/adc.72.2.125"},{"key":"2021121019243283800_R31","doi-asserted-by":"crossref","unstructured":"Rosth\u00f8j S, Nielsen S, Pedersen FK. Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura. Danish ITP Study Group. Acta Paediatr.\u2008\u20081996;85:910-915","DOI":"10.1111\/j.1651-2227.1996.tb14183.x"},{"key":"2021121019243283800_R32","doi-asserted-by":"crossref","unstructured":"Saxon BR, Blanchette VS, Butchart S, Lim-Yin J, Poon AO. Reticulated platelet counts in the diagnosis of acute immune thrombocytopenic purpura. J Pediatr Hematol Oncol.\u2008\u20081998;20:44-48","DOI":"10.1097\/00043426-199801000-00007"},{"key":"2021121019243283800_R33","doi-asserted-by":"crossref","unstructured":"Schultz KR, Strahlendorf C, Warrier I, Ravin-dranath Y. Cyclosporin A therapy of immunemediated thrombocytopenia in children. Blood.\u2008\u20081995;85:1406-1408","DOI":"10.1182\/blood.V85.5.1406.bloodjournal8551406"},{"key":"2021121019243283800_R34","doi-asserted-by":"crossref","unstructured":"Tamary H, Kaplinsky C, Levy I, et al. Chronic childhood idiopathic thrombocytopenia purpura: long-term follow-up. Acta Paediatr.\u2008\u20081994;83:931-934","DOI":"10.1111\/j.1651-2227.1994.tb13175.x"},{"key":"2021121019243283800_R35","doi-asserted-by":"crossref","unstructured":"Tarantino MD, Madden RM, Fennewald DL,Patel CC, Bertolone SJ. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr.\u2008\u20081999;134:21-26","DOI":"10.1016\/S0022-3476(99)70367-7"},{"key":"2021121019243283800_R36","doi-asserted-by":"crossref","unstructured":"Van Hoff J, Ritchey AK. Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura. J Pediatr.\u2008\u20081988;113:563-566","DOI":"10.1016\/S0022-3476(88)80654-1"},{"key":"2021121019243283800_R37","doi-asserted-by":"crossref","unstructured":"Walker RW, Walker W. Idiopathic thrombocytopenia, initial illness and long term follow up. Arch Dis Child.\u2008\u20081994;59:316-322","DOI":"10.1136\/adc.59.4.316"},{"key":"2021121019243283800_R38","doi-asserted-by":"crossref","unstructured":"Warrier I, Bussel JB, Valdez L, Barbosa J,Beardsley DS. Safety and efficacy of low-dose intravenous immune globulin (IVIG)treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group. J Pediatr Hematol Oncol.\u2008\u20081997;19:197-201","DOI":"10.1097\/00043426-199705000-00004"},{"key":"2021121019243283800_R39","doi-asserted-by":"crossref","unstructured":"Winiarski J. Mechanisms in childhood idiopathic thrombocytopenic purpura (ITP). Acta Paediatr.\u2008\u20081998;424(suppl):54-56","DOI":"10.1111\/j.1651-2227.1998.tb01235.x"}],"container-title":["Pediatrics In Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/21\/3\/95\/991038\/pir95.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/21\/3\/95\/991038\/pir95.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T03:12:18Z","timestamp":1726283538000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article\/21\/3\/95\/61576\/Idiopathic-Thrombocytopenic-Purpura"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,1]]},"references-count":39,"aliases":["10.1542\/pir.21-3-95"],"journal-issue":{"issue":"3","published-online":{"date-parts":[[2000,3,1]]},"published-print":{"date-parts":[[2000,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/pir.21.3.95","relation":{},"ISSN":["0191-9601","1526-3347"],"issn-type":[{"value":"0191-9601","type":"print"},{"value":"1526-3347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,1]]}}}